A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|6|853-861

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.6, 2015-12, pp. : 853-861

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solifenacin: a new drug for the treatment of overactive bladder and detrusor overactivity

By Wyndaele Jean-Jacques  

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 485-494

Future Medicine

Access to resources Recommend Favorite

An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity

By  

Urologia Internationalis, Vol. 89, Iss. 3, 2012-07 ,pp. : 259-269

Karger

Access to resources Recommend Favorite

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite

Do Patients with Urodynamically Proven Infravesical Obstruction and Detrusor Overactivity Have a Higher Risk for Long-Term Bothersome Symptoms after Brachytherapy in Comparison to Patients Treated with Radical Prostatectomy for Localized Prostate Cancer?

By  

Current Urology, Vol. 2, Iss. 3, 2009-01 ,pp. : 135-141

Karger

Access to resources Recommend Favorite